Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Huh?
No probs SI, GL
Okay boss. :)
No evil intent.
Si, well don’t bother , just saying
You like a few took it out of context swap, just goes to show you and a few others like to make a fool of him, I know what he meant pity you can’t take him at face value .
Dr. Arthur Caplan, a bioethicist and professor at NYU Langone Health, told Yahoo Finance that back in March, many drug companies were against the idea, saying such trials would be too risky. But that’s changing now. In addition, NIAID recently revealed it has been preparing for the possibility of running a challenge trial.
And even with several vaccines in late stages of clinical trials, the remainder of the more than 180 candidates globally are likely to benefit if a human challenge trial is used.
Caplan, who is on the advisory board of 1DaySooner, which has advocated for such trials and has thousands of petitioners who say they would sign up for one, said it still makes sense to pursue, because “we still don’t know if the first round of vaccines will work.”
hVivo’s Catchpole said the challenge trial “can really expedite judging the efficacy of a vaccine in a safe and informative way.”
A traditional clinical trial stops when a certain number of infected individuals is reached — and if a majority of those infected are in a placebo group, the vaccine is considered a success. But it also depends on participants’ habits and locations — if they are in a hotspot or are roaming around in the middle of one intentionally trying to expose themselves, versus if they are in the middle of a low-incidence area or are following safety protocols.
Catchpole said that since the company announced it intentions in March, it began working on the strategy and protocols with experts. In addition, hVivo is working closely with the U.K. government.
Cathal Friel, hVivo’s executive chairperson, told Yahoo Finance that in addition to the U.K. launch, the company is also in final stages for establishing a quarantine center in Australia, and “shortly thereafter, in North America.” But where on the continent has yet to be revealed. In both cases, hVivo would be partnering, rather than running, the trials.
I think about a month ago he said 50% six months, doubling every year; which is of course incorrect. But I'll happily take either estimate!
Err, 50% of 30p is 15p = 45p ( 1st 6 months)
50% of 45p= 22.5p = 67.5p (2nd 6 months)
100%of 30p is 30p = 60p ( for 12 months)
Just sayin' :)
I don't think it's an exact science...
This topic has been discussed before.
I think you will find I am correct.
He stated in a presentation 50% every 6 months mon ami
Don’t be stupid swap , he explained that 100% over the year
Slightly more than 100%
He said 50% every 6 months
He’s said 100% per annum so why do we need to quiz him about it, if things change I’m sure he will tell us all.
Nope. He said 100% per annum. By my maths we will get to there at some point.
Maybe someone brighter at maths than me might quiz him on it.
Maybe so but he never said that it’s a 1 billion company did he ?
I read an interview where he said he had a $100m company. He liked the sound of $100m because it never made it to ÂŁ100m.
I reckon this time he is aiming for ÂŁ1bn.
This long game will be good for all of us .
Ceejay of course he’s playing a long game , can’t you all see it ?.
I agree! But then why didn't he put something in the original rns to say significant upgrade to profit this year.
He is playing the long game. Build the company to a good value for a takeover in a year or two. In the mean time throw off non core and realise some value.
There will be a RNS tomorrow announcing the private Pharma company challenge study deals, we will drop 5% when it lands :)
The potential revenue associated with this deal.